EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Major Components of Cerebrospinal Fluid Dictate the Characteristics of Inhibitors against Amyloid-Beta Aggregation

Andrius Sakalauskas iD, Mantas Ziaunys, Ruta Snieckute iD, Agne Janoniene, Dominykas Veiveris, Mantas Zvirblis, Virginija Dudutiene, Vytautas Smirnovas iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24065991 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Andrius Sakalauskas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biotechnology, Life Sciences Center, Vilnius University, LT-10257 Vilnius, Lithuania. Hauptthemen laut MEDLINE: Alzheimer Disease, Catechin. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lietuvos Mokslo Taryba, Research Council of Lithuania.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The main pathological hallmark of Alzheimer’s disease (AD) is the aggregation of amyloid-β into amyloid fibrils, leading to a neurodegeneration cascade. The current medications are far from sufficient to prevent the onset of the disease, hence requiring more research to find new alternative drugs for curing AD. In vitro inhibition experiments are one of the primary tools in testing whether a molecule may be potent to impede the aggregation of amyloid-beta peptide (Aβ42). However, kinetic experiments in vitro do not match the mechanism found when aggregating Aβ42 in cerebrospinal fluid. The different aggregation mechanisms and the composition of the reaction mixtures may also impact the characteristics of the inhibitor molecules. For this reason, altering the reaction mixture to resemble components found in cerebrospinal fluid (CSF) is critical to partially compensate for the mismatch between the inhibition experiments in vivo and in vitro. In this study, we used an artificial cerebrospinal fluid that contained the major components found in CSF and performed Aβ42 aggregation inhibition studies using oxidized epigallocatechin-3-gallate (EGCG) and fluorinated benzenesulfonamide VR16-09. This led to a discovery of a complete turnaround of their inhibitory characteristics, rendering EGCG ineffective while significantly improving the efficacy of VR16-09. HSA was the main contributor in the mixture that significantly increased the anti-amyloid characteristics of VR16-09.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCatechinHumansPeptide FragmentsAmyloid beta-PeptidesAmyloid

Stichwörter der Autor:innen

EGCGVR16-09aggregation kineticsamyloid-betainhibitionnear-physiological conditionsprotein aggregation

Substanzen

Peptide FragmentsAmyloid beta-PeptidesAmyloidCatechin

Autor:innen und Institutionen

  • Institute of Biotechnology, Life Sciences Center, Vilnius University, LT-10257 Vilnius, Lithuania.

ORCID-Profile: Andrius Sakalauskas, Ruta Snieckute, Vytautas Smirnovas

Förderung

  • Lietuvos Mokslo Taryba
  • Research Council of Lithuania

Zitieren

APA

Sakalauskas, A., Ziaunys, M., Snieckute, R., Janoniene, A., Veiveris, D., Zvirblis, M., Dudutiene, V., & Smirnovas, V. (2023). The Major Components of Cerebrospinal Fluid Dictate the Characteristics of Inhibitors against Amyloid-Beta Aggregation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065991

Vancouver

Sakalauskas A, Ziaunys M, Snieckute R, Janoniene A, Veiveris D, Zvirblis M, et al. The Major Components of Cerebrospinal Fluid Dictate the Characteristics of Inhibitors against Amyloid-Beta Aggregation. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065991

BibTeX
@article{Sakalauskas2023,
  author = {Sakalauskas, Andrius and Ziaunys, Mantas and Snieckute, Ruta and Janoniene, Agne and Veiveris, Dominykas and Zvirblis, Mantas and Dudutiene, Virginija and Smirnovas, Vytautas},
  title = {The Major Components of Cerebrospinal Fluid Dictate the Characteristics of Inhibitors against Amyloid-Beta Aggregation},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24065991}
}
Kostenlos starten →